Assessment of cognitive functions in bipolar I disorder: A 1-year naturalistic follow-up study

2018 ◽  
Vol 20 (3) ◽  
pp. 248-259 ◽  
Author(s):  
Rajesh Sagar ◽  
Anamika Sahu ◽  
Raman Deep Pattanayak ◽  
Biswadip Chatterjee
Keyword(s):  
Cognitive Functions ◽  
Bipolar I Disorder ◽  
Follow Up Study

Changes in oral and cognitive functions among older Japanese dental outpatients: A 2‐year follow‐up study

2021 ◽  
Author(s):  
Shinsuke Mizutani ◽  
Rui Egashira ◽  
Masahiro Yamaguchi ◽  
Keiko Tamai ◽  
Mizuki Yoshida ◽  
...  
Keyword(s):  
Cognitive Functions ◽  
Follow Up Study

scholarly journals High level of persistence of pediatric bipolar-I disorder from childhood onto adolescent years: A four year prospective longitudinal follow-up study

2011 ◽  
Vol 45 (10) ◽  
pp. 1273-1282 ◽  
Author(s):  
Janet Wozniak ◽  
Carter R. Petty ◽  
Meghan Schreck ◽  
Alana Moses ◽  
Stephen V. Faraone ◽  
...  
Keyword(s):  
Bipolar I Disorder ◽  
Follow Up Study ◽  
High Level ◽  
Prospective Longitudinal

P1-192: Cognitive functions and CSF biomarkers in MCI: Preliminary findings of follow-up study

2013 ◽  
Vol 9 ◽  
pp. P220-P221
Author(s):  
Monika Mandecka ◽  
Budziszewska Maria ◽  
Anna Barczak ◽  
Anna Filipek ◽  
Maria Styczynska ◽  
...  
Keyword(s):  
Cognitive Functions ◽  
Csf Biomarkers ◽  
Follow Up Study

scholarly journals Cognitive Functions of Bipolar Disorder Patients in Remission on Monotherapy: A Follow-Up Study

2017 ◽  
Author(s):  
Vesile Cankorur Senturk ◽  
Hilal Demirel ◽  
Damla Yucel ◽  
Sibel Cakir ◽  
Sermin Kesebir ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Cognitive Functions ◽  
Follow Up Study

The assessment of cognitive functions in patients with isolated cerebellar infarctions: A follow-up study

2021 ◽  
Vol 765 ◽  
pp. 136252
Author(s):  
Yuksel Erdal ◽  
Seyma Perk ◽  
Cahit Keskinkılıc ◽  
Banu Bayramoglu ◽  
Abdullah Soydan Mahmutoglu ◽  
...  
Keyword(s):  
Cognitive Functions ◽  
Follow Up Study

Course of neurocognitive function in first treatment bipolar I disorder: One-year follow-up study

2017 ◽  
Vol 249 ◽  
pp. 286-292 ◽  
Author(s):  
Christine Demmo ◽  
Trine Vik Lagerberg ◽  
Sofie R Aminoff ◽  
Tone Hellvin ◽  
Levi R. Kvitland ◽  
...  
Keyword(s):  
Neurocognitive Function ◽  
Bipolar I Disorder ◽  
Follow Up Study ◽  
One Year

scholarly journals The effects of topiramate on cognitive functions of patients with focal epilepsy - a follow-up study in a Serbian sample

2019 ◽  
Vol 147 (3-4) ◽  
pp. 193-198
Author(s):  
Nenad Milosevic ◽  
Biljana Salak-Djokic ◽  
Mirjana Dejanovic ◽  
Mirjana Stojanovic-Tasic ◽  
Tatjana Novakovic ◽  
...  
Keyword(s):  
Antiepileptic Drugs ◽  
Cognitive Functions ◽  
Focal Epilepsy ◽  
Neuropsychological Testing ◽  
Depression Scale ◽  
Percentage Change ◽  
Brain Pathology ◽  
Follow Up Study ◽  
Wide Range

Introduction/Objective. The aim of this follow-up study was to determine the effects of topiramate therapy on cognitive functions in patients with pharmacoresistant focal epilepsy. Methods. The study sample comprised of 40 topiramate naive patients. The topiramate starting dose was 25 mg, with a fortnightly titration schedule of 25 mg. A wide range of cognitive functions was evaluated through extensive neuropsychological testing at baseline and six months after reaching the target dose (200 mg/day). Results. The most common side effects following the introduction of topiramate were cognitive impairments, reported by 45% of the participants. The neuropsychological scores on attention, executive function, verbal content recall, improved cognitive flexibility, as well as visuospatial ability and speech, obtained at six-month follow-up were significantly lower than at baseline. However, statistically significant correlation between neuropsychological scores and the number of antiepileptic drugs taken alongside topiramate could not be established. Similarly, no statistically significant differences were noted between the percentage of reduced neuropsychological scores at follow-up pertaining to patients with lower and higher baseline cognitive performance. Moreover, regression analysis indicates that the percentage change in the majority of cognitive scores is unrelated to the age at the epilepsy onset, epilepsy duration, presence of brain pathology on magnetic resonance imaging and percentage change in the depression scale score. Conclusion. Despite slow introduction and administration of a relatively small dose, topiramate exhibits adverse effects on a wide range of cognitive functions, which appear unrelated to the number of additional antiepileptic drugs, baseline cognitive functioning, age at the onset of epilepsy and its duration, presence of brain pathology and the extent of depressive symptoms.

The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: A prospective three-year follow-up study

2013 ◽  
Vol 209 (3) ◽  
pp. 353-360 ◽  
Author(s):  
Wing Chung Chang ◽  
Jennifer Yee Man Tang ◽  
Christy Lai Ming Hui ◽  
Gloria Hoi Yan Wong ◽  
Sherry Kit Wa Chan ◽  
...  
Keyword(s):  
Cognitive Functions ◽  
Negative Symptoms ◽  
First Episode ◽  
Follow Up Study ◽  
Premorbid Adjustment ◽  
First Episode Schizophrenia ◽  
Relationship Of ◽  
The Relationship
Sign in / Sign up

Export Citation Format

Share Document